My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 177

    1.

    Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.

    Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W.

    Diabetes. 2002 Oct;51(10):3025-32.PMID: 12351443 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and Type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity.

    Misra A, Sinha S, Kumar M, Jagannathan NR, Pandey RM.

    Diabet Med. 2003 May;20(5):361-7.PMID: 12752484 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans.

    Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Häring HU, Jacob S.

    Diabetes. 2001 Nov;50(11):2579-84.PMID: 11679437 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.

    Bernroider E, Brehm A, Krssak M, Anderwald C, Trajanoski Z, Cline G, Shulman GI, Roden M.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5559-65. Epub 2005 Jul 5.PMID: 15998784 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

    Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Häring HU.

    Diabetes. 1999 May;48(5):1113-9.PMID: 10331418 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

    Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P.

    Diabetologia. 2007 Jan;50(1):113-20. Epub 2006 Nov 9.PMID: 17093944 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.

    Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, Kinoshita J, Ooka A, Kumashiro N, Igarashi Y, Kyogoku S, Maehara T, Kawasumi M, Hirose T, Kawamori R.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3191-6. Epub 2005 Mar 15.PMID: 15769987 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.

    Diabetes. 2003 Aug;52(8):1943-50.PMID: 12882909 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.

    Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.

    Metabolism. 2007 Oct;56(10):1418-24.PMID: 17884455 [PubMed - indexed for MEDLINE]Related articles

    10.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects.

    Lara-Castro C, Newcomer BR, Rowell J, Wallace P, Shaughnessy SM, Munoz AJ, Shiflett AM, Rigsby DY, Lawrence JC, Bohning DE, Buchthal S, Garvey WT.

    Metabolism. 2008 Jan;57(1):1-8.PMID: 18078853 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

    Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2004 Jun;28(6):783-9.PMID: 15024400 [PubMed - indexed for MEDLINE]Related articles

    13.

    Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.

    Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H.

    Diabetologia. 2001 Jul;44(7):824-33.PMID: 11508266 [PubMed - indexed for MEDLINE]Related articles

    14.

    Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.

    Jucker BM, Schaeffer TR, Haimbach RE, Mayer ME, Ohlstein DH, Smith SA, Cobitz AR, Sarkar SK.

    Metabolism. 2003 Feb;52(2):218-25.PMID: 12601636 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.

    Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L.

    Am J Clin Nutr. 2006 Dec;84(6):1374-9.PMID: 17158419 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

    Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI.

    Diabetes. 2005 Mar;54(3):603-8.PMID: 15734833 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.

    Ravikumar B, Gerrard J, Dalla Man C, Firbank MJ, Lane A, English PT, Cobelli C, Taylor R.

    Diabetes. 2008 Sep;57(9):2288-95. Epub 2008 Jun 5.PMID: 18535187 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver.

    Stadler M, Anderwald C, Pacini G, Zbyn S, Promintzer-Schifferl M, Mandl M, Bischof M, Gruber S, Nowotny P, Luger A, Prager R, Krebs M.

    Diabetes. 2009 Oct 15. [Epub ahead of print]PMID: 19833878 [PubMed - as supplied by publisher]Related articles

    20.

    Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes.

    Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L.

    Am J Clin Nutr. 2009 Jun;89(6):1760-5. Epub 2009 Apr 29.PMID: 19403641 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity